Dr. Moh'd Khushman
Claim this profileWashington University School of Medicine
Studies Colorectal Cancer
Studies Solid Tumors
7 reported clinical trials
16 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
Beta-catenin positive
APC positive
2Solid Tumors
Stage IV
dMMR positive
dMMR negative
Affiliated Hospitals
Clinical Trials Moh'd Khushman is currently running
Nous-209 Vaccine
for Metastatic Cancer
Ref: Protocol v9.0, dated 7Nov2023. NOUS-209-01 is a multicenter, open-label, multiple cohorts, clinical study, designed to evaluate safety, tolerability, and immunogenicity, and to detect any preliminary evidence of anti-tumor activity of Nous-209 genetic polyvalent vaccine plus pembrolizumab combination therapy in adult subjects with unresectable or metastatic deficient mismatch repair (dMMR) or MSI-H CRC, gastric, or gastro-esophageal junction (G-E junction) tumors. Nous-209 is based on a heterologous prime/boost regimen composed of the Great Ape Adenovirus GAd20-209-FSP used for priming and Modified Vaccinia virus Ankara MVA-209-FSP used for boosting. The Phase I portion of the study is a first-in-human (FIH) clinical study with a primary objective to elucidate the safety and tolerability of Nous-209 in addition to establishing the recommended Phase 2 dose (RP2D), whereas the Phase II was introduced to assess efficacy as the primary objective.
Recruiting1 award Phase 1 & 225 criteria
FOG-001
for Cancer
This trial is testing FOG-001, a new medicine, to see if it is safe and effective for patients with advanced or spreading solid tumors. FOG-001 works by blocking certain proteins to stop cancer cells from growing.
Recruiting1 award Phase 1 & 28 criteria
More about Moh'd Khushman
Clinical Trial Related4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Moh'd Khushman has experience with
- CDX-301
- CDX-1140
- FOG-001
- Fluorouracil
- Irinotecan Hydrochloride
- Oxaliplatin
Breakdown of trials Moh'd Khushman has run
Colorectal Cancer
Solid Tumors
Tumors
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Moh'd Khushman specialize in?
Moh'd Khushman focuses on Colorectal Cancer and Solid Tumors. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Beta-catenin positive.
Is Moh'd Khushman currently recruiting for clinical trials?
Yes, Moh'd Khushman is currently recruiting for 6 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Moh'd Khushman has studied deeply?
Yes, Moh'd Khushman has studied treatments such as CDX-301, CDX-1140, FOG-001.
What is the best way to schedule an appointment with Moh'd Khushman?
Apply for one of the trials that Moh'd Khushman is conducting.
What is the office address of Moh'd Khushman?
The office of Moh'd Khushman is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.